Andrew Turitz, SVP - Business Development at Teladoc Health, Inc. (TDOC), sold 7,718 shares at $183.18 ($1.4M) on 2021-03-05, disclosed to the SEC on 2021-03-09.
Seasonal sale ($1.4M) by SVP - Business Development — this insider has traded TDOC in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $183.18 | 2,155 | $395K | 27.5% |
| 2 | $183.18 | 2,155 | $395K | 27.5% |
| 3 | $194.15 | 511 | $99K | 6.9% |
| 4 | $194.15 | 511 | $99K | 6.9% |
| 5 | $188.15 | 1,193 | $224K | 15.6% |
| 6 | $188.15 | 1,193 |
| $224K |
| 15.6% |
| Total | $186.17 avg | 7,718 | $1.4M | 100% |
| Filing → |
| TDOC | SELL | 2024-06-04 | $18K | — | Filing → |
| TDOC | SELL | 2024-03-06 | $164K | — | Filing → |
| TDOC | SELL | 2024-03-05 | $187K | — | Filing → |